The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trying to define “high tumor burden” in non-small cell lung cancer: A Delphi survey.
 
Xabier Mielgo-Rubio
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Roche
 
Maria Sereno
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - Roche
 
Oliver Higuera
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Roche; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Merck; Roche
 
Raquel Cervera
No Relationships to Disclose
 
Luis Cabezon-Gutierrez
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Speakers' Bureau - Amgen; Angelini Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Grunenthal; Ipsen; Kyowa Kirin; Leo Pharma; Lilly; Merck Serono; Mundipharma; Pfizer; Roche; ROVI